Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 3.203
Filtrer
1.
Int J Nanomedicine ; 19: 9109-9120, 2024.
Article de Anglais | MEDLINE | ID: mdl-39253061

RÉSUMÉ

Background and Purpose: Growth hormone-releasing hormone (GHRH) agonist, a 29-amino acid peptide, shows significant potential in treating myocardial infarction (MI) by aiding the repair of injured heart tissue. The challenge lies in the effective on-site delivery of GHRH agonist. This study explores the use of a targetable delivery system employing ROS-responsive PEG-PPS-PEG polymers to encapsulate and deliver GHRH agonist MR409 for enhanced therapeutic efficacy. Methods: We synthesized a self-assembling poly (ethylene glycol)-poly (propylene sulfide)-poly (ethylene glycol) polymer (PEG-PPS-PEG) amphiphilic polymer responsive to reactive oxygen species (ROS). The hydrophilic peptide GHRH agonist MR409 was encapsulated within these polymers to form nano PEG-PPS-PEG@MR409 vesicles (NPs). Cardiomyocyte apoptosis was induced under hypoxia and serum-free culture condition for 24 hours, and their production of ROS was detected by fluorescence dye staining. The cellular uptake of PEG-PPS-PEG@MR409 NPs was observed using fluorescence-labeled MR409. Targeting ability and therapeutic efficacy were evaluated using a mouse MI model. Results: PEG-PPS-PEG@MR409 NPs were efficiently internalized by cardiomyocytes, reducing ROS levels and apoptosis. These NPs exhibited superior targeting to the infarcted heart compared to naked MR409 peptide. With a reduced injection frequency (once every three days), PEG-PPS-PEG@MR409 NPs significantly promoted cardiac function recovery post-MI, matching the efficacy of daily MR409 injections. Conclusion: ROS-responsive PEG-PPS-PEG polymers provide a novel and effective platform for the targeted delivery of GHRH agonist peptides, improving cardiac function and offering a new approach for peptide therapy in MI treatment.


Sujet(s)
Infarctus du myocarde , Myocytes cardiaques , Polyéthylène glycols , Espèces réactives de l'oxygène , Animaux , Polyéthylène glycols/composition chimique , Polyéthylène glycols/pharmacocinétique , Polyéthylène glycols/pharmacologie , Espèces réactives de l'oxygène/métabolisme , Souris , Infarctus du myocarde/traitement médicamenteux , Myocytes cardiaques/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine , Hormone de libération de l'hormone de croissance/agonistes , Hormone de libération de l'hormone de croissance/pharmacocinétique , Hormone de libération de l'hormone de croissance/administration et posologie , Apoptose/effets des médicaments et des substances chimiques , Sulfures/composition chimique , Sulfures/pharmacocinétique , Sulfures/pharmacologie , Sulfures/administration et posologie , Peptides/composition chimique , Peptides/pharmacologie , Peptides/pharmacocinétique , Peptides/administration et posologie , Mâle , Souris de lignée C57BL
2.
Molecules ; 29(18)2024 Sep 13.
Article de Anglais | MEDLINE | ID: mdl-39339342

RÉSUMÉ

Microgreens have recently gained popularity owing to their reliable economic and nutritional value. This study aimed to increase the quality of microgreen broccoli via treatment with different concentrations (1%, IPB-1; 3%, IPB-3; 5%, IPB-5; or 7%, IPB-7 w/v) of illite-a natural mineral powder. The results showed that the illite treatments considerably increased the content of mineral elements, such as Ca, P, and K; of vitamin C; and of free amino acids; and also increased the total weight of the broccoli sprouts. The content of sulforaphane, a bioactive compound, also increased by up to 47% with illite treatment, with the highest increase being in the IPB-5 group. However, several of the parameters were lower in the IPB-7 group. Aromatic compounds were categorized by functional groups such as hydrocarbons which numbered 36, 30, 34, 28, and 30 in the control, IPB-1, IPB-3, IPB-5, and IPB-7 groups, respectively. We found 16, 15, 15, 13, and 14 sulfides, including dimethyl sulfide, in the control, IPB-1, IPB-3, IPB-5, and IPB-7 groups, respectively. Additionally, aldehydes, comprising seven compounds, were detected in the IPB-1, IPB-3, IPB-5, and IPB-7 groups. Illite treatment significantly increased the activities of antioxidants such as DPPH and the polyphenol content of the microgreens. These results indicate a potential role for appropriate illite doses in microgreen treatment to address multinutrient deficiencies and to increase the quality of microgreen vegetables.


Sujet(s)
Antioxydants , Brassica , Brassica/composition chimique , Brassica/croissance et développement , Antioxydants/pharmacologie , Antioxydants/composition chimique , Sulfoxydes , Minéraux/analyse , Isothiocyanates/pharmacologie , Isothiocyanates/composition chimique , Acide ascorbique/analyse , Plant/composition chimique , Plant/croissance et développement , Sulfures/pharmacologie , Sulfures/analyse , Sulfures/composition chimique
3.
Int J Mol Sci ; 25(18)2024 Sep 11.
Article de Anglais | MEDLINE | ID: mdl-39337318

RÉSUMÉ

Traditionally, garlic has a valuable role in preventing and reducing the incidence of many diseases and pathophysiological disorders. Consequently, some researchers have focused on the beneficial cardiovascular properties of diallyl trisulfide (DATS), the most potent polysulfide isolated from garlic. Therefore, in this review, we collected the available data on DATS, its biochemical synthesis, metabolism and pharmacokinetics, and gathered the current knowledge and the role of DATS in cardiovascular diseases. Overall, this review summarizes the cardioprotective effects of DATS and brings together all previous findings on its protective molecular mechanisms, which are mainly based on the potent anti-apoptotic, anti-inflammatory, and antioxidant potential of this polysulfide. Our review is an important cornerstone for further basic and clinical research on DATS as a new therapeutic agent for the treatment of numerous heart diseases.


Sujet(s)
Composés allyliques , Maladies cardiovasculaires , Sulfures , Sulfures/usage thérapeutique , Sulfures/pharmacologie , Composés allyliques/pharmacologie , Humains , Maladies cardiovasculaires/traitement médicamenteux , Maladies cardiovasculaires/métabolisme , Maladies cardiovasculaires/prévention et contrôle , Animaux , Antioxydants/pharmacologie , Antioxydants/usage thérapeutique , Ail/composition chimique , Cardiotoniques/pharmacologie , Cardiotoniques/usage thérapeutique , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/usage thérapeutique , Apoptose/effets des médicaments et des substances chimiques , Système cardiovasculaire/effets des médicaments et des substances chimiques , Système cardiovasculaire/métabolisme
4.
Sci Rep ; 14(1): 21519, 2024 09 14.
Article de Anglais | MEDLINE | ID: mdl-39277622

RÉSUMÉ

The common housefly, Musca domestica, known for transmitting over 100 infections, was studied using green-synthesized Cadmium Sulfide nanoparticles (CdS NPs) from Agaricus bisporus. These CdS NPs were tested on third-instar larvae under laboratory conditions using dipping and feeding methods with concentrations (75, 100, 125, 150, 175, and 200 µg/mL). The toxicity, measured by LC50, was found to be 138 µg/mL for dipping treatment and 123 µg/mL for feeding treatment. Analysis with an energy-dispersive X-ray microanalyzer confirmed Cd accumulation in the larval midgut, indicating penetration of CdS NPs into the organism, which may potentially increase their toxicity. CdS NPs caused disruptions in Heat Shock Protein 70, cell apoptosis, and various biochemical components. Scanning electron microscopy revealed morphological abnormalities in larvae, pupae, and adults exposed to CdS NPs. Ultrastructural examination showed significant midgut tissue abnormalities in larvae treated with 123 µg/mL of CdS NPs. Our study demonstrated that green-synthesized CdS NPs from A. bisporus can effectively control the development of M. domestica larvae.


Sujet(s)
Agaricus , Composés du cadmium , Mouches domestiques , Larve , Sulfures , Animaux , Mouches domestiques/effets des médicaments et des substances chimiques , Sulfures/composition chimique , Sulfures/pharmacologie , Composés du cadmium/toxicité , Larve/effets des médicaments et des substances chimiques , Nanoparticules métalliques/composition chimique , Nanoparticules métalliques/toxicité , Nanoparticules/composition chimique , Modèles biologiques
5.
ACS Appl Mater Interfaces ; 16(33): 43387-43399, 2024 Aug 21.
Article de Anglais | MEDLINE | ID: mdl-39136145

RÉSUMÉ

A wide variety of methods are being developed to ultimately defeat cancer; while some of these strategies have shown highly positive results, there are serious obstacles to overcome to completely eradicate this disease. So, it is crucial to construct multifunctional nanostructures possessing intelligent capabilities that can be utilized to treat cancer. A possible strategy for producing these multifunctional nanostructures is to combine various cancer treatment techniques. Based on this point of view, we successfully synthesized multifunctional HCuS@Cu2S@Au-P(NIPAM-co-AAm)-PpIX nanohybrids. The peculiarities of these thermosensitive polymer-modified and protoporphyrin IX (PpIX)-loaded hollow nanohybrids are that they combine photodynamic therapy (PDT), sonodynamic therapy (SDT), and photothermal therapy (PTT) with an intelligent design. As an all-in-one nanohybrids, HCuS@Cu2S@Au-P(NIPAM-co-AAm)-PpIX nanohybrids were employed in the SDT-PDT-PTT combination therapy, which proved to have a synergistic therapeutic effect for in vitro tumor treatments against breast tumors.


Sujet(s)
Cuivre , Photothérapie dynamique , Thérapie photothermique , Protoporphyrines , Humains , Cuivre/composition chimique , Cuivre/pharmacologie , Protoporphyrines/composition chimique , Protoporphyrines/pharmacologie , Protoporphyrines/usage thérapeutique , Photosensibilisants/composition chimique , Photosensibilisants/pharmacologie , Photosensibilisants/usage thérapeutique , Photosensibilisants/synthèse chimique , Or/composition chimique , Femelle , Ultrasonothérapie/méthodes , Nanostructures/composition chimique , Nanostructures/usage thérapeutique , Tumeurs du sein/thérapie , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/anatomopathologie , Lignée cellulaire tumorale , Sulfures/composition chimique , Sulfures/pharmacologie , Animaux
6.
J Am Chem Soc ; 146(34): 24053-24060, 2024 Aug 28.
Article de Anglais | MEDLINE | ID: mdl-39136646

RÉSUMÉ

Macrocyclic peptides are promising scaffolds for the covalent ligand discovery. However, platforms enabling the direct identification of covalent macrocyclic ligands in a high-throughput manner are limited. In this study, we present an mRNA display platform allowing selection of covalent macrocyclic inhibitors using 1,3-dibromoacetone-vinyl sulfone (DBA-VS). Testcase selections on TEV protease resulted in potent covalent inhibitors with diverse cyclic structures, among which cTEV6-2, a macrocyclic peptide with a unique C-terminal cyclization, emerged as the most potent covalent inhibitor of TEV protease described to-date. This study outlines the workflow for integrating chemical functionalization─installation of a covalent warhead─with mRNA display and showcases its application in targeted covalent ligand discovery.


Sujet(s)
ARN messager , ARN messager/antagonistes et inhibiteurs , Cyclisation , Sulfures/composition chimique , Sulfures/pharmacologie , Peptides cycliques/composition chimique , Peptides cycliques/pharmacologie , Peptides cycliques/synthèse chimique , Composés macrocycliques/composition chimique , Composés macrocycliques/pharmacologie , Composés macrocycliques/synthèse chimique , Sulfones/composition chimique , Sulfones/pharmacologie , Découverte de médicament , Inhibiteurs de protéases/pharmacologie , Inhibiteurs de protéases/composition chimique , Inhibiteurs de protéases/synthèse chimique , Structure moléculaire
7.
PLoS One ; 19(8): e0307537, 2024.
Article de Anglais | MEDLINE | ID: mdl-39213335

RÉSUMÉ

Currently, no safe vaccine against leishmaniasis is available. So far, different control strategies against numerous reservoir hosts and biological vectors have not been environment-friendly and feasible. Hence, employing medicinal components and conventional drugs could be a promising approach to developing novel therapeutic alternatives. This study aimed to explore diallyl sulfide (DAS), a dynamic constituent of garlic, alone and in a mixture with meglumine antimoniate (MAT as standard drug) using in vitro and animal model experiments against Leishmania major stages. The binding affinity of DAS and four major defense elements of the immune system (iNOS, IFN-É£, IL-12, and TNF-α) was used to predict the predominant binding mode for molecular docking configurations. Herein, we conducted a broad range of experiments to monitor and assess DAS and MAT potential treatment outcomes. DAS, combined with MAT, displayed no cytotoxicity and employed a powerful anti-leishmanial activity, notably against the clinical stage. The function mechanism involved immunomodulation through the induction of Th1 cytokine phenotypes, triggering a high apoptotic profile, reactive oxygen species (ROS) production, and antioxidant enzymes. This combination significantly decreased cutaneous lesion diameter and parasite load in BALB/c mice. The histopathological findings performed the infiltration of inflammatory cells associated with T-lymphocytes, particularly CD4+ phenotypes, as determined by biochemical markers in alleviating the amastigote stage and improving the pathological changes in L. major infected BALB/c mice. Therefore, DAS and MAT deserve further advanced therapeutic development and should be considered as possible candidates for treating volunteer cases with cutaneous leishmaniasis in designing an upcoming clinical trial.


Sujet(s)
Composés allyliques , Antiprotozoaires , Leishmania major , Leishmaniose cutanée , Antimoniate de méglumine , Souris de lignée BALB C , Simulation de docking moléculaire , Sulfures , Animaux , Leishmania major/effets des médicaments et des substances chimiques , Antimoniate de méglumine/pharmacologie , Sulfures/pharmacologie , Sulfures/composition chimique , Antiprotozoaires/pharmacologie , Antiprotozoaires/composition chimique , Antiprotozoaires/usage thérapeutique , Leishmaniose cutanée/traitement médicamenteux , Leishmaniose cutanée/immunologie , Leishmaniose cutanée/parasitologie , Souris , Composés allyliques/pharmacologie , Composés allyliques/composition chimique , Composés allyliques/usage thérapeutique , Composés organométalliques/pharmacologie , Composés organométalliques/composition chimique , Composés organométalliques/usage thérapeutique , Modèles animaux de maladie humaine , Femelle , Espèces réactives de l'oxygène/métabolisme , Méglumine/pharmacologie , Méglumine/composition chimique , Cytokines/métabolisme
8.
Curr Med Sci ; 44(4): 799-808, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39096478

RÉSUMÉ

OBJECTIVE: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells. METHODS: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Cell viability was detected by Cell Counting Kit-8 (CCK-8) assay, and cell apoptosis and reactive oxygen species (ROS) by flow cytometry. Western blotting was conducted to examine the levels of apoptotic proteins, including cleaved caspase-3 and poly(ADP-ribose) polymerase (PARP). Moreover, the human long noncoding RNA (lncRNA) microarray was used to analyze gene expression after glutamine deprivation, and results were confirmed with quantitative RT-PCR (qRT-PCR). The expression of metallothionein 2A (MT2A) was suppressed using siRNA. Cell growth and apoptosis were further detected by CCK-8 assay and flow cytometry, respectively, in cells with MT2A knockdown. RESULTS: Glutamine deprivation or treatment with BPTES inhibited cell growth and induced apoptosis in SKM-1 cells. The lncRNA microarray result showed that the expression of MT family genes was significantly upregulated after glutamine deprivation. MT2A knockdown increased apoptosis, while proliferation was not affected in SKM-1 cells. In addition, metformin inhibited cell growth and induced apoptosis in SKM-1 cells. Both glutamine deprivation and metformin enhanced the sensitivity of SKM-1 cells to cytarabine. Furthermore, the combination of glutamine deprivation with metformin exhibited synergistic antileukemia effects on SKM-1 cells. CONCLUSION: Targeting glutamine metabolism in combination with metformin is a promising new therapeutic strategy for AML.


Sujet(s)
Apoptose , Glutamine , Leucémie aigüe myéloïde , Metformine , Metformine/pharmacologie , Humains , Glutamine/métabolisme , Glutamine/pharmacologie , Leucémie aigüe myéloïde/traitement médicamenteux , Leucémie aigüe myéloïde/génétique , Leucémie aigüe myéloïde/métabolisme , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Glutaminase/génétique , Glutaminase/métabolisme , Thiadiazoles/pharmacologie , Sulfures/pharmacologie , Synergie des médicaments , Cytarabine/pharmacologie , Espèces réactives de l'oxygène/métabolisme , ARN long non codant/génétique
9.
Mol Biol Rep ; 51(1): 916, 2024 Aug 19.
Article de Anglais | MEDLINE | ID: mdl-39158746

RÉSUMÉ

INTRODUCTION: In end stage renal disease )ESRD(, reduced EPO production resulted in decreased oxygen diffusion that cause Hypoxia-inducible factors (HIFs) stabilization. The mechanism of beneficial effects of H2S in chronic kidney disease (CKD) is the aim of the present study to examine the effects of the H2S donor sodium hydrosulfide (NaHS) on renal function parameters, oxidative stress indices and expression levels of HIF-2α gene and erythropoietin protein in 5/6 nephrectomy-induced chronic renal failure in rats. METHODS AND MATERIALS: Male rats were assigned into 3 groups (n = 8): Sham, CKD and NaHS groups. In the CKD group, 5/6 nephrectomy was performed. In the sham group, rats were anesthetized but 5/6 nephrectomy was not induced. In the NaHS group, 30 µmol/L of NaHS in drinking water for 8 weeks was adminstrated 4 weeks after 5/6 nephrectomy induction. At the end of the 12 week, blood and renal tissues were taken to evaluate renal function parameters, oxidative stress indices and expression levels of HIF-2α gene and erythropoietin protein. RESULTS: The induction of 5/6 nephrectomy significantly caused renal dysfunction, oxidative stress, increased HIF-2α gene expression and decreased erythropoietin levels in renal tissue samples. NaHS administration resulted in a marked improvement in renal function and oxidative stress indicators, a marked reduction in HIF-2α gene expression as well as an increase in erythropoietin protein levels in comparison with the CKD group. CONCLUSION: In this study, regional hypoxia and oxidative stress in CKD, may cause the stabilization of the HIFs complexes, although erythropoietin synthesis was not increased due to destructive effects of CKD on the kidney tissues. Administration of NaHS caused up-regulating HIF-erythropoietin signaling pathway.


Sujet(s)
Facteurs de transcription à motif basique hélice-boucle-hélice , Érythropoïétine , Sulfure d'hydrogène , Néphrectomie , Stress oxydatif , Insuffisance rénale chronique , Animaux , Érythropoïétine/génétique , Érythropoïétine/métabolisme , Érythropoïétine/pharmacologie , Mâle , Rats , Sulfure d'hydrogène/métabolisme , Insuffisance rénale chronique/métabolisme , Insuffisance rénale chronique/traitement médicamenteux , Facteurs de transcription à motif basique hélice-boucle-hélice/métabolisme , Facteurs de transcription à motif basique hélice-boucle-hélice/génétique , Stress oxydatif/effets des médicaments et des substances chimiques , Rein/métabolisme , Rein/effets des médicaments et des substances chimiques , Régulation positive/effets des médicaments et des substances chimiques , Sulfures/pharmacologie , Modèles animaux de maladie humaine
10.
Sci Rep ; 14(1): 19304, 2024 08 20.
Article de Anglais | MEDLINE | ID: mdl-39164280

RÉSUMÉ

First time compared the different metals doped ZnS nanoparticles for antibacterial and liver cancer cell line. In this study, copper, aluminum and nickel doped ZnS NPs were synthesized via co-precipitation method. The XRD analysis was confirmed the presence of cubic crystal structure and crystallite size decreased from 6 to 3 nm with doping elements. While as SEM micro-grains were revealed slightly irregular and agglomerated morphology with the presence of dopant elements. The presence of different dopant elements such as Cu, Al and Ni in ZnS NPs was identified via EDX analysis. The FTIR results demonstrate various vibrational stretching and bending modes attached to the surface of ZnS nanomaterials. After that the well diffusion method was used to conduct in-vitro bioassays for evaluation of antibacterial and anticancer activities against E.coli and B.cereus, as well as HepG2 liver cancer cell line. Our findings unveil exceptional results with maximum inhibition zone of approximately 9 to 23 mm observed against E.coli and 12 to 27 mm against B.cereus, respectively. In addition, the significant reduction in cell viability was achieved against the HepG2 liver cancer cell line. These favorable results highlight the potential of Ni doped ZnS NPs for various biomedical applications. In future, the doped ZnS nanomaterials will be suitable for hyperthermia therapy and wound healing process.


Sujet(s)
Aluminium , Antibactériens , Antinéoplasiques , Cuivre , Escherichia coli , Nickel , Sulfures , Composés du zinc , Humains , Nickel/composition chimique , Antibactériens/pharmacologie , Antibactériens/composition chimique , Sulfures/composition chimique , Sulfures/pharmacologie , Cuivre/composition chimique , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Aluminium/composition chimique , Composés du zinc/composition chimique , Escherichia coli/effets des médicaments et des substances chimiques , Cellules HepG2 , Nanoparticules métalliques/composition chimique , Survie cellulaire/effets des médicaments et des substances chimiques , Bacillus cereus/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne , Nanoparticules/composition chimique
11.
Int J Mol Sci ; 25(15)2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-39125961

RÉSUMÉ

Garlic is a vegetable with numerous pro-health properties, showing high antioxidant capacity, and cytotoxicity for various malignant cells. The inhibition of cell proliferation by garlic is mainly attributed to the organosulfur compounds (OSCs), but it is far from obvious which constituents of garlic indeed participate in the antioxidant and cytotoxic action of garlic extracts. This study aimed to obtain insight into this question by examining the antioxidant activity and cytotoxicity of six OSCs and five phenolics present in garlic. Three common assays of antioxidant activity were employed (ABTS● decolorization, DPPH● decolorization, and FRAP). Cytotoxicity of both classes of compounds to PEO1 and SKOV-3 ovarian cancer cells, and MRC-5 fibroblasts was compared. Negligible antioxidant activities of the studied OSCs (alliin, allicin, S-allyl-D-cysteine, allyl sulfide, diallyl disulfide, and diallyl trisulfide) were observed, excluding the possibility of any significant contribution of these compounds to the total antioxidant capacity (TAC) of garlic extracts estimated by the commonly used reductive assays. Comparable cytotoxic activities of OSCs and phenolics (caffeic, p-coumaric, ferulic, gallic acids, and quercetin) indicate that both classes of compounds may contribute to the cytotoxic action of garlic.


Sujet(s)
Composés allyliques , Antioxydants , Disulfures , Ail , Phénols , Extraits de plantes , Sulfures , Acides sulfiniques , Ail/composition chimique , Humains , Antioxydants/pharmacologie , Antioxydants/composition chimique , Phénols/pharmacologie , Phénols/composition chimique , Disulfures/pharmacologie , Disulfures/composition chimique , Lignée cellulaire tumorale , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Acides sulfiniques/pharmacologie , Acides sulfiniques/composition chimique , Sulfures/pharmacologie , Sulfures/composition chimique , Composés allyliques/pharmacologie , Composés allyliques/composition chimique , Composés du soufre/pharmacologie , Composés du soufre/composition chimique , Cystéine/analogues et dérivés , Cystéine/composition chimique , Cystéine/pharmacologie , Survie cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Fibroblastes/effets des médicaments et des substances chimiques , Fibroblastes/métabolisme
12.
ACS Nano ; 18(33): 22257-22274, 2024 Aug 20.
Article de Anglais | MEDLINE | ID: mdl-39121010

RÉSUMÉ

Iron metabolism has emerged as a promising target for cancer therapy; however, the innate metabolic compensatory capacity of cancer cells significantly limits the effectiveness of iron metabolism therapy. Herein, bioactive gallium sulfide nanodots (GaSx), with dual functions of "reprogramming" and "interfering" iron metabolic pathways, were successfully developed for tumor iron metabolism therapy. The constructed GaSx nanodots ingeniously harness hydrogen sulfide (H2S) gas, which is released in response to the tumor microenvironment, to reprogram the inherent transferrin receptor 1 (TfR1)-ferroportin 1 (FPN1) iron metabolism axis in cancer cells. Concurrently, the gallium ions (Ga3+) derived from GaSx act as a biochemical "Trojan horse", mimicking the role of iron and displacing it from essential biomolecular binding sites, thereby influencing the fate of cancer cells. By leveraging the dual mechanisms of Ga3+-mediated iron disruption and H2S-facilitated reprogramming of iron metabolic pathways, GaSx prompted the initiation of a paraptosis-apoptosis hybrid pathway in cancer cells, leading to marked suppression of tumor proliferation. Importantly, the dysregulation of iron metabolism induced by GaSx notably increased tumor cell susceptibility to both chemotherapy and immune checkpoint blockade (ICB) therapy. This study underscores the therapeutic promise of gas-based interventions and metal ion interference strategies for the tumor metabolism treatment.


Sujet(s)
Apoptose , Gallium , Fer , , Animaux , Humains , Souris , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Apoptose/effets des médicaments et des substances chimiques , Transporteurs de cations , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Gallium/composition chimique , Gallium/pharmacologie , Sulfure d'hydrogène/métabolisme , Sulfure d'hydrogène/composition chimique , Sulfure d'hydrogène/pharmacologie , Fer/métabolisme , Fer/composition chimique , Tumeurs/traitement médicamenteux , Tumeurs/métabolisme , Tumeurs/anatomopathologie , /effets des médicaments et des substances chimiques , Récepteurs à la transferrine/métabolisme , Sulfures/composition chimique , Sulfures/pharmacologie , Microenvironnement tumoral/effets des médicaments et des substances chimiques
13.
J Pharmacol Sci ; 156(2): 69-76, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39179336

RÉSUMÉ

Despite the widespread recognition of the global concern regarding the onset of cardiovascular diseases in a significant number of patients following cancer treatment, definitive strategies for prevention and treatment remain elusive. In this study, we established systems to evaluate the influence of anti-cancer drugs on the quality control of mitochondria, pivotal for energy metabolism, using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Osimertinib, an epidermal growth factor receptor tyrosine kinase inhibitor used for treatment in lung cancer, reportedly increases the risk of cardiovascular disease. However, its underlying mechanism is largely unknown. Here, we found that the treatment of hiPSC-CMs with osimertinib and doxorubicin, but not trastuzumab and cisplatin, revealed a concentration-dependent impairment of respiratory function accompanied by mitochondrial fission. We previously reported the significant role of sulfur metabolism in maintaining mitochondrial quality in the heart. Co-treatment with various inorganic sulfur donors (Na2S, Na2S2, Na2S3) alongside anti-cancer drugs demonstrated that Na2S attenuated the cardiotoxicity of osimertinib but not doxorubicin. Osimertinib decreased intracellular reduced sulfur levels, while Na2S treatment suppressed the sulfur leakage, suggesting its potential in mitigating osimertinib-induced cardiotoxicity. These results imply the prospect of inorganic sulfides, such as Na2S, as a seed for precision pharmacotherapy to alleviate osimertinib's cardiotoxic effects.


Sujet(s)
Acrylamides , Dérivés de l'aniline , Antinéoplasiques , Doxorubicine , Cellules souches pluripotentes induites , Mitochondries , Myocytes cardiaques , Sulfures , Humains , Acrylamides/pharmacologie , Myocytes cardiaques/effets des médicaments et des substances chimiques , Myocytes cardiaques/métabolisme , Dérivés de l'aniline/pharmacologie , Cellules souches pluripotentes induites/effets des médicaments et des substances chimiques , Antinéoplasiques/effets indésirables , Antinéoplasiques/pharmacologie , Doxorubicine/effets indésirables , Sulfures/pharmacologie , Mitochondries/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Cardiotoxicité/prévention et contrôle , Cardiotoxicité/étiologie , Cellules cultivées , Dynamique mitochondriale/effets des médicaments et des substances chimiques , Soufre , Indoles , Pyrimidines
14.
ACS Nano ; 18(29): 19232-19246, 2024 Jul 23.
Article de Anglais | MEDLINE | ID: mdl-38996055

RÉSUMÉ

Despite the superior efficacy of radiotherapy in esophageal squamous cell carcinoma (ESCC), radioresistance by cancer stem cells (CSCs) leads to recurrence, metastasis, and treatment failure. Therefore, it is necessary to develop CSC-based therapies to enhance radiotherapy. miR-339-5p (miR339) is involved in stem cell division and DNA damage checkpoint signaling pathways based on ESCC cohort. miR339 inhibited ESCC cell stemness and enhanced radiation-induced DNA damage by targeting USP8, suggesting that it acts as a potential CSC regulator and radiosensitizer. Considering the limited circulating periods and poor tumor-targeting ability of miRNA, a multifunctional nanoplatform based on bismuth sulfide nanoflower (Bi@PP) is developed to efficiently deliver miR339 and improve radioresistance. Intriguingly, Bi@PP encapsulates more miR339 owing to their flower-shaped structure, delivering more than 1000-fold miR339 into cells, superior to free miR339 alone. Besides being used as a carrier, Bi@PP is advantageous for dynamically monitoring the distribution of delivered miR339 in vivo while simultaneously inhibiting tumor growth. Additionally, Bi@PP/miR339 can significantly enhance radiotherapy efficacy in patient-derived xenograft models. This multifunctional platform, incorporating higher miRNA loading capacity, pH responsiveness, hypoxia relief, and CT imaging, provides another method to promote radiosensitivity and optimize ESCC treatment.


Sujet(s)
Bismuth , Tumeurs de l'oesophage , microARN , Cellules souches tumorales , Sulfures , Bismuth/composition chimique , Bismuth/pharmacologie , Humains , microARN/génétique , microARN/métabolisme , Tumeurs de l'oesophage/anatomopathologie , Tumeurs de l'oesophage/métabolisme , Tumeurs de l'oesophage/traitement médicamenteux , Sulfures/composition chimique , Sulfures/pharmacologie , Animaux , Cellules souches tumorales/métabolisme , Cellules souches tumorales/effets des médicaments et des substances chimiques , Cellules souches tumorales/anatomopathologie , Souris , Radiotolérance/effets des médicaments et des substances chimiques , Ubiquitin thiolesterase/métabolisme , Ubiquitin thiolesterase/antagonistes et inhibiteurs , Souris nude , Souris de lignée BALB C , Prolifération cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Carcinome épidermoïde de l'oesophage/anatomopathologie , Carcinome épidermoïde de l'oesophage/métabolisme , Carcinome épidermoïde de l'oesophage/génétique
15.
BMC Plant Biol ; 24(1): 680, 2024 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-39020266

RÉSUMÉ

Hydrogen sulfide (H2S) has emerged as a novel endogenous gas signaling molecule, joining the ranks of nitric oxide (NO) and carbon monoxide (CO). Recent research has highlighted its involvement in various physiological processes, such as promoting root organogenesis, regulating stomatal movement and photosynthesis, and enhancing plant growth, development, and stress resistance. Tobacco, a significant cash crop crucial for farmers' economic income, relies heavily on root development to affect leaf growth, disease resistance, chemical composition, and yield. Despite its importance, there remains a scarcity of studies investigating the role of H2S in promoting tobacco growth. This study exposed tobacco seedlings to different concentrations of NaHS (an exogenous H2S donor) - 0, 200, 400, 600, and 800 mg/L. Results indicated a positive correlation between NaHS concentration and root length, wet weight, root activity, and antioxidant enzymatic activities (CAT, SOD, and POD) in tobacco roots. Transcriptomic and metabolomic analyses revealed that treatment with 600 mg/L NaHS significantly effected 162 key genes, 44 key enzymes, and two metabolic pathways (brassinosteroid synthesis and aspartate biosynthesis) in tobacco seedlings. The addition of exogenous NaHS not only promoted tobacco root development but also potentially reduced pesticide usage, contributing to a more sustainable ecological environment. Overall, this study sheds light on the primary metabolic pathways involved in tobacco root response to NaHS, offering new genetic insights for future investigations into plant root development.


Sujet(s)
Nicotiana , Racines de plante , Sulfures , Nicotiana/génétique , Nicotiana/effets des médicaments et des substances chimiques , Nicotiana/physiologie , Racines de plante/effets des médicaments et des substances chimiques , Racines de plante/croissance et développement , Racines de plante/métabolisme , Racines de plante/génétique , Sulfures/pharmacologie , Transcriptome/effets des médicaments et des substances chimiques , Métabolomique , Voies et réseaux métaboliques/effets des médicaments et des substances chimiques , Plant/effets des médicaments et des substances chimiques , Plant/croissance et développement , Plant/génétique , Plant/métabolisme , Sulfure d'hydrogène/métabolisme , Sulfure d'hydrogène/pharmacologie , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes végétaux/effets des médicaments et des substances chimiques
16.
Curr Pharm Biotechnol ; 25(12): 1617-1628, 2024.
Article de Anglais | MEDLINE | ID: mdl-39034838

RÉSUMÉ

BACKGROUND: This article presents a new and environmentally friendly method for generating DH-CdSNPs (cadmium sulfide nanoparticles) ranging from 5-10 nm in size. A green synthesis method for the development of inorganic nanoparticles was developed a few years back for their applications in diverse fields, such as medicine, bioimaging and remediation. The biogenic synthesis of these nanoparticles containing daruharidra (Berberis aristata) and cadmium sulfide is an effective alternative. AIMS: By employing Daruharidra extract as a herbal analog, we aim to minimize the risks and adverse effects that come along with the use of other chemically synthesized nanoparticles. This study's main goal was to investigate the potential of these nanoparticles as powerful antibacterial and anticancer agents. METHODS: We used a crude powdered daruharidra extract as a stabilizer ingredient to create CdSbased nanoformulations in an environmentally responsible way. By exposing the breast cancer cell line (MDAMB-231) and ovarian teratocarcinoma cell line (PA1) to these nanoformulations, we were able to evaluate their anticancer activities. Additionally, flow cytometry analysis was conducted to scrutinize the process of cell cycle arrest and apoptosis in reference to anticancer studies. Furthermore, DH-CdSNPs were applied on different gram-positive as well as gramnegative bacteria in a disc diffusion assay to ascertain their antibacterial activity. Nanoparticles were tested on bacterial strains to check if they were resistant after the MIC or minimum inhibitory concentration. RESULTS: The cytotoxicity of nanoparticles was tested by MTT assay. The impact of increasing concentrations of NPs on cell lines was tested, revealing a cytotoxic effect. The half-maximal inhibitory concentration values for a 24-hour treatment were determined to be 95.74µg/ml for ovarian cancer cells and 796.25 µg/ml for breast cancer cells. Treatment with DH-CdSNP resulted in a noteworthy increase in early apoptotic cells, with percentages rising from approximately 3% to 14.5% in ovarian cancer cell lines and from 4% to 13.6% in breast cancer cell lines. Furthermore, the NPs induced arrest of the cell cycle, specifically in the interphase of G2 and mitosis phase, with DNA damage observed in sub G1 in ovarian cancer cells and G0/G1 arrest observed in breast cancer cells. Additionally, the NPs exhibited exceptional potency against both gram-positive as well as gram-negative bacteria. CONCLUSION: Less research has been done on using bioinspired DH-CdSNP to deliver anticancer medications. The amalgamation of plant extract and the DH-CdSNP could cause a paradigm shift in the cancer therapy approach. The findings revealed that the biosynthesized DH-CdSNP limited the growth of human breast and ovarian cancer cells. This property can be further investigated against a variety of additional cell lines to determine whether this property makes the DH-CdSNP a promising treatment alternative. The results obtained from these nanoformulations exhibit faster efficacy compared to traditional medications.


Sujet(s)
Antibactériens , Antinéoplasiques , Tumeurs du sein , Composés du cadmium , Nanoparticules , Tumeurs de l'ovaire , Sulfures , Humains , Antibactériens/pharmacologie , Antibactériens/composition chimique , Composés du cadmium/composition chimique , Femelle , Lignée cellulaire tumorale , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/anatomopathologie , Sulfures/pharmacologie , Sulfures/composition chimique , Tumeurs de l'ovaire/traitement médicamenteux , Tumeurs de l'ovaire/anatomopathologie , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Nanoparticules/composition chimique , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Apoptose/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne , Survie cellulaire/effets des médicaments et des substances chimiques
17.
ISME J ; 18(1)2024 Jan 08.
Article de Anglais | MEDLINE | ID: mdl-38995932

RÉSUMÉ

Marine planktonic predator-prey interactions occur in microscale seascapes, where diffusing chemicals may act either as chemotactic cues that enhance or arrest predation, or as elemental resources that are complementary to prey ingestion. The phytoplankton osmolyte dimethylsulfoniopropionate (DMSP) and its degradation products dimethylsulfide (DMS) and acrylate are pervasive compounds with high chemotactic potential, but there is a longstanding controversy over whether they act as grazing enhancers or deterrents. Here, we investigated the chemotactic responses of three herbivorous dinoflagellates to point-sourced, microscale gradients of dissolved DMSP, DMS, and acrylate. We found no evidence for acrylate being a chemotactic repellent and observed a weak attractor role of DMS. DMSP behaved as a strong chemoattractor whose potential for grazing facilitation through effects on swimming patterns and aggregation depends on the grazer's feeding mode and ability to incorporate DMSP. Our study reveals that predation models will fail to predict grazing impacts unless they incorporate chemotaxis-driven searching and finding of prey.


Sujet(s)
Chimiotaxie , Dinoflagellida , Herbivorie , Composés de sulfonium , Composés de sulfonium/métabolisme , Dinoflagellida/physiologie , Acrylates , Sulfures/métabolisme , Sulfures/pharmacologie , Phytoplancton/physiologie , Animaux , Comportement prédateur , Chaine alimentaire
18.
Molecules ; 29(14)2024 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-39064957

RÉSUMÉ

Cholangiocarcinoma (CCA) is a cancer with a poor prognosis due to difficulties in diagnosis and limited treatment options, highlighting the urgent need for new targeted therapies. In a clinical setting, we found that leukotriene levels in bile were higher than in serum. Immunohistochemical analysis of surgically resected samples also revealed that CysLT receptor 1 (CysLTR1) was more highly expressed in CCA than in normal bile duct tissue, prompting us to investigate leukotriene as a potential therapeutic target in CCA. In vitro studies using CCA cell lines expressing CysLTR1 showed that leukotriene D4, a major ligand of CysLTR1, promoted cell proliferation, with increased phosphorylation of AKT and extracellular signal-regulated kinase 1/2 (ERK1/2). Additionally, treatment with two clinically available anti-allergic drugs-zileuton, an inhibitor of CysLT formation, and montelukast, a CysLTR1 inhibitor-had inhibitory effects on cell proliferation and migratory capacity, accompanied by the reduced phosphorylation of AKT and ERK1/2. Furthermore, the simultaneous administration of both drugs synergistically enhanced the inhibitory effect on cell proliferation. Our study suggests that use of these drugs may represent a novel approach to treat CCA through drug repositioning.


Sujet(s)
Tumeurs des canaux biliaires , Prolifération cellulaire , Cholangiocarcinome , Hydroxy-urée , Antagonistes des leucotriènes , Quinoléines , Récepteurs aux leucotriènes , Sulfures , Humains , Cholangiocarcinome/traitement médicamenteux , Cholangiocarcinome/métabolisme , Cholangiocarcinome/anatomopathologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Récepteurs aux leucotriènes/métabolisme , Antagonistes des leucotriènes/pharmacologie , Antagonistes des leucotriènes/usage thérapeutique , Lignée cellulaire tumorale , Tumeurs des canaux biliaires/traitement médicamenteux , Tumeurs des canaux biliaires/métabolisme , Tumeurs des canaux biliaires/anatomopathologie , Sulfures/pharmacologie , Quinoléines/pharmacologie , Hydroxy-urée/analogues et dérivés , Hydroxy-urée/pharmacologie , Hydroxy-urée/usage thérapeutique , Acétates/pharmacologie , Acétates/composition chimique , Mâle , Cyclopropanes/pharmacologie , Cyclopropanes/usage thérapeutique , Mouvement cellulaire/effets des médicaments et des substances chimiques , Femelle , Adulte d'âge moyen , Protéines proto-oncogènes c-akt/métabolisme , Évolution de la maladie , Leucotriènes/métabolisme , Phosphorylation/effets des médicaments et des substances chimiques , Sujet âgé , Leucotriène D4/métabolisme , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques
19.
Plant Signal Behav ; 19(1): 2375673, 2024 Dec 31.
Article de Anglais | MEDLINE | ID: mdl-38972043

RÉSUMÉ

OBJECTIVE: This study aimed to investigate the regulatory effects of exogenous hydrogen sulfide (H2S) on seed germination, seedling growth, and reactive oxygen species (ROS) homeostasis in alfalfa under chromium (Cr) ion (III) stress. METHODS: The effects of 0-4 mM Cr(III) on the germination and seedling growth of alfalfa were first assessed. Subsequently, following seed NaHS immersion, the influence of H2S on alfalfa seed germination and seedling growth under 2 mM Cr(III) stress was investigated, and the substance contents and enzyme activities associated with ROS metabolism were quantified. RESULTS: Compared to the control group, alfalfa plant germination was delayed under 2 mM Cr(III) stress for up to 48 h (p < 0.05). At 120 h, the total seedling length was approximately halved, and the root length was roughly one-third of the control. Treatment with 0.02-0.1 mM NaHS alleviated the delay in germination and root growth inhibition caused by 2 mM Cr(III) stress, resulting in an increased ratio of root length to hypocotyl length from 0.57 to 1 above. Additionally, immersion in 0.05 mM NaHS reduced hydrogen peroxide (H2O2) and oxygen-free radicals (O2· -) levels (p < 0.05), boosted glutathione (GSH) levels (p < 0.05), and notably enhanced catalase (CAT), ascorbate peroxidase (APX), and glutathione reductase (GR) activities (p < 0.05) compared to the 2 mM Cr(III) stress treatment group. CONCLUSION: Seed immersion in NaHS mitigated the delay in germination and inhibition of root elongation under 2 mM Cr(III) stress. This effect is likely attributed to the regulation of intracellular ROS homeostasis and redox balance through enzymatic and non-enzymatic systems; thus, providing a potential mechanism for combating oxidative stress.


Sujet(s)
Chrome , Germination , Medicago sativa , Espèces réactives de l'oxygène , Graines , Sulfures , Medicago sativa/effets des médicaments et des substances chimiques , Medicago sativa/métabolisme , Medicago sativa/croissance et développement , Graines/effets des médicaments et des substances chimiques , Graines/croissance et développement , Chrome/pharmacologie , Germination/effets des médicaments et des substances chimiques , Sulfures/pharmacologie , Espèces réactives de l'oxygène/métabolisme , Plant/effets des médicaments et des substances chimiques , Plant/métabolisme , Plant/croissance et développement , Stress physiologique/effets des médicaments et des substances chimiques , Peroxyde d'hydrogène/métabolisme , Oxygène/métabolisme , Racines de plante/effets des médicaments et des substances chimiques , Racines de plante/métabolisme , Racines de plante/croissance et développement
20.
Nat Commun ; 15(1): 5529, 2024 Jul 02.
Article de Anglais | MEDLINE | ID: mdl-38956039

RÉSUMÉ

Left unchecked, plant-parasitic nematodes have the potential to devastate crops globally. Highly effective but non-selective nematicides are justifiably being phased-out, leaving farmers with limited options for managing nematode infestation. Here, we report our discovery of a 1,3,4-oxadiazole thioether scaffold called Cyprocide that selectively kills nematodes including diverse species of plant-parasitic nematodes. Cyprocide is bioactivated into a lethal reactive electrophilic metabolite by specific nematode cytochrome P450 enzymes. Cyprocide fails to kill organisms beyond nematodes, suggesting that the targeted lethality of this pro-nematicide derives from P450 substrate selectivity. Our findings demonstrate that Cyprocide is a selective nematicidal scaffold with broad-spectrum activity that holds the potential to help safeguard our global food supply.


Sujet(s)
Antihelminthiques antinématodes , Cytochrome P-450 enzyme system , Nematoda , Animaux , Cytochrome P-450 enzyme system/métabolisme , Nematoda/effets des médicaments et des substances chimiques , Antihelminthiques antinématodes/pharmacologie , Sulfures/pharmacologie , Sulfures/composition chimique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE